For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote monitoring initiatives, can improve enrollment.
Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations
April 5th 2024Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.